Navigation Links
Rexin-G Controls Tumor Growth and Improves Survival in Chemotherapy-Resistant Sarcoma and Osteosarcoma: Phase I/II and Phase II Studies, ASCO 2009
Date:5/18/2009

SAN MARINO, Calif., May 18 /PRNewswire/ -- Epeius Biotechnologies (www.epeiusbiotech.com) today announced the results of two related studies using Rexin-G, a tumor-targeted anti-cancer agent designed to seek-out and destroy metastatic cancers that have spread throughout the body. While Rexin-G is currently approved for the treatment of all solid tumors in the Republic of the Philippines, Epeius Biotech is conducting a series of advanced Phase I/II studies and a Phase II confirmatory trial in the U.S. The Phase I/II study evaluating the safety and efficacy of Rexin-G in chemotherapy-resistant metastatic bone and soft tissue sarcomas (ASCO Annual Meeting 2009, #10513) demonstrated that Rexin-G was well-tolerated with no dose-limiting toxicity. Moreover, Rexin-G exhibited dose-dependent efficacy in terms of tumor control rates, progression-free survival, and overall survival, thus validating both the efficiency of the tumor-targeting technology and the pharmacological mechanisms of action.

The efficacy and safety of Rexin-G was further confirmed in a Phase II study for chemotherapy-resistant osteosarcoma. Again, in the absence of dose-limiting toxicity, Rexin-G was demonstrated to control tumor growth, prolong progression-free survival, and improve overall survival in osteosarcoma patients who have failed known therapies. It is important to note that these outstanding results, were achieved when Rexin-G was administered as monotherapy-unlike many other so-called targeted biologics where one or more toxic agents are used in combination in order to achieve even marginal results. Based on a critical analysis of its performance in the clinic, the U.S. FDA recently granted Rexin-G Orphan Drug Status for both soft tissue sarcoma and osteosarcoma. The results of these studies will be presented by Dr. Sant P. Chawla, Sarcoma Oncology Center, Santa Monica, CA, and discussed by Dr.
'/>"/>

SOURCE Epeius Biotechnologies
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. FDA Approves the Opening of a Phase II Registration Protocol Using REXIN-G(R) for Osteosarcoma in California U.S.A.
2. Lesson From the States: Lack of Cost Controls Derailed California Health Reform, Led to Budget Overruns and Unaffordable Policies in Massachusetts
3. China Shenghuo Announces Management Expansion and Enhanced Internal Controls
4. Enhanced skin cancer risk linked to defects in cellular aging controls
5. Best Practice Database Supports Chemistry, Manufacturing & Controls (CMC) Operations
6. Gems Sensors & Controls Introduces Highly Accurate FDA Compliant Flow Sensor
7. Molecular partnership controls daily rhythms, body metabolism
8. NIH scientists find a novel mechanism that controls the development of autoimmunity
9. Gladstone scientists identify single microRNA that controls blood vessel development
10. MicroRNA controls expression of oncogenes
11. Monkey Controls Robotic Arm With Brain
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/4/2015)... ... August 04, 2015 , ... ... has achieved Office of the National Coordinator for Health Information Technology (ONC-HIT) ... delivers the highest quality personal health record and patient portal solution to ...
(Date:8/4/2015)... ... , ... Updated enrollment data on the top U.S. health plans, as collected ... http://www.AISHealth.com . The data is free to all registered users to AISHealth.com. Based ... on the website’s “Data” section include:, , Top 25 U.S. ...
(Date:8/4/2015)... ... ... Rock Your Hair, http://www.rockyourhair.com has signed on as the title ... signed Lexi Noel, dubbed the Teen Beauty Queen by her fans as the company’s ... the company. , The Pop & Rock Beauty Bash is the only teen ...
(Date:8/4/2015)... ... August 04, 2015 , ... The goal of looking younger ... desire for invasive surgery to achieve this ideal is not. But minimally invasive procedures ... without the high cost or lengthy recovery time, according to Valerie Goldburt, MD, ...
(Date:8/4/2015)... Coast, Florida (PRWEB) , ... August 04, 2015 ... ... Sankyo Inc have awarded independent educational grants in support of an interaction simulation ... and DVT/PE." The activity is jointly provided by Medical Learning Institute Inc. and ...
Breaking Medicine News(10 mins):Health News:MedicaSoft's HealthCenter Earns ONC-HIT Certification from Drummond Group 2Health News:MedicaSoft's HealthCenter Earns ONC-HIT Certification from Drummond Group 3Health News:Atlantic Information Services Website Offers Up-to-Date U.S. Health Plan Enrollment Data 2Health News:Rock Your Hair Signs On As Title Sponsor For The HYPE! Projects Pop & Rock Beauty Bash Tour 2Health News:Considering fillers, tighteners or laser resurfacing? 2Health News:Considering fillers, tighteners or laser resurfacing? 3Health News:Considering fillers, tighteners or laser resurfacing? 4Health News:Innovative Medical Interactive Simulation Session to be presented at upcoming Continuing Education Company Education (CME) Conferences. 2Health News:Innovative Medical Interactive Simulation Session to be presented at upcoming Continuing Education Company Education (CME) Conferences. 3
... is the text of a letter to Senator Reid from the ... , Majority Leader , United States Senate , Washington DC , ... debate very carefully. We applaud you and the entire Congress for ... most difficult public policy issue. And, we applaud your concern for ...
... Many parents grew up with medical adages or advice that have ... are five common myths about children,s eye health and the medical ... at Childrens Hospital Los Angeles. , Myth #1. Sitting ... Fact: "Sitting in front of the TV or a computer screen ...
... , LOS ANGELES, Oct. 9 ... was a smashing success for the retailer known as the ... and Torrid fans packed the courtyard at the Fashion Institute ... celebrate fashion, honor people who work to motivate women and ...
... The American Society of Hematology (ASH) is ... ASH Visitor Training Program, which builds hematologic capacity ... medical professionals from developing countries receive valuable clinical, ... at a host institution under the mentorship of ...
... loss, researchers say , FRIDAY, Oct. 9 (HealthDay News) -- ... which could lead to weaker bones and increased risk of ... D for them. , "Vitamin D is essential to maintaining ... loss due to the nature of hormone therapy and chemotherapy. ...
... US Farms, Inc., (Pink Sheets: USFM) a diversified supplier ... eBay store. The companies, Aloe Vera based Health & Beauty ... largest online eCommerce websites in the world. US Farms, Inc. ... of purchasing its Aloe365 line of Aloe Vera Juice and ...
Cached Medicine News:Health News:Concord Coalition Leaders Send Letter to Senator Reid on Healthcare Reform Bill 2Health News:Concord Coalition Leaders Send Letter to Senator Reid on Healthcare Reform Bill 3Health News:Concord Coalition Leaders Send Letter to Senator Reid on Healthcare Reform Bill 4Health News:Concord Coalition Leaders Send Letter to Senator Reid on Healthcare Reform Bill 5Health News:Concord Coalition Leaders Send Letter to Senator Reid on Healthcare Reform Bill 6Health News:Concord Coalition Leaders Send Letter to Senator Reid on Healthcare Reform Bill 7Health News:Concord Coalition Leaders Send Letter to Senator Reid on Healthcare Reform Bill 8Health News:Concord Coalition Leaders Send Letter to Senator Reid on Healthcare Reform Bill 9Health News:Concord Coalition Leaders Send Letter to Senator Reid on Healthcare Reform Bill 10Health News:Myths and Facts About Children's Eye Health 2Health News:Myths and Facts About Children's Eye Health 3Health News:Myths and Facts About Children's Eye Health 4Health News:Myths and Facts About Children's Eye Health 5Health News:Torrid's Model Search Winners, Celebrities Celebrate Fashion and Help Support the National Breast Cancer Foundation at the House of Dreams Event 2Health News:Medical professionals from developing nations to pursue hematology training 2Health News:Vitamin D Good for Breast Cancer Patients 2Health News:US Farms, Inc. Aloe Vera Products Now Available on eBay 2Health News:US Farms, Inc. Aloe Vera Products Now Available on eBay 3
(Date:8/4/2015)... , Aug. 4, 2015  Ironshore Pharmaceuticals ... with Restore Health, a company specializing in personalized ... double-blind clinical trial, designed to evaluate the safety ... development to treat Attention-deficit/hyperactivity disorder (ADHD). This is ... Restore Health originally partnered with Ironshore in ...
(Date:8/3/2015)... , Aug. 3, 2015 Discovery Laboratories, ... company focused on developing aerosolized KL4 surfactant therapies ... and webcast at 8:30 a.m. Eastern Time on Tuesday ... discuss the 2015 second quarter financial results along ... issue a press release announcing the second quarter ...
(Date:8/3/2015)... -- Your doctor has recommended surgery for your foot ... possible outcome. Your orthopaedic foot and ankle specialist is ... a three-part online series to help you ... Orthopaedic Foot & Ankle Society (AOFAS) both before ... heal as quickly as possible. For example, ...
Breaking Medicine Technology:Restore Health Secures Another Clinical Trial with Ironshore Pharmaceuticals & Development 2Discovery Labs to Hold Conference Call on Tuesday August 11, 2015 to Discuss Second Quarter 2015 Financial Results and Other Business Updates 2Patient Guide: How to Prepare for Surgery 2
... Corporation (OTCBB: VYST), creators of Vytex® Natural Rubber ... significantly reduces antigenic proteins and other non-rubber particles ... technical paper at the 13th International Latex Conference ... of Vytex® Natural Rubber Latex Leads to Strong ...
... July 27, 2011 VirtualScopics, Inc. (NASDAQ: ... clinical trials, today announced that after the market closes ... second quarter 2011 financial results. VirtualScopics, President and Chief ... Officer, Molly Henderson, will host a conference call on ...
Cached Medicine Technology:Vystar® Corporation Spotlights Advantages of Vytex® NRL at the 13th Annual International Latex Conference 2Vystar® Corporation Spotlights Advantages of Vytex® NRL at the 13th Annual International Latex Conference 3VirtualScopics Schedules Second Quarter 2011 Earnings Announcement 2
Weitlaner-Locktite retractors, blunt, 11 cm total length....
Baby Weitlaner retractor, blunt, 4"....
Bruns (Volkmann) bone curette, with Novotex plastic handle (autoclavable in autoclave up to 143C by 3 bar), 9, oval....
15" overall length, 5" handle....
Medicine Products: